CARGO Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	20.92	5.4	1.52
Research & Development	75.79	29.37	4.46
Operating Expenses	96.71	34.77	5.98
Operating Income	-96.71	-34.77	-5.98
Interest Expense / Income	1.6	4.94	0
Other Expense / Income	-0.17	1.24	-0.13
Pretax Income	-98.15	-40.95	-5.85
Net Income	-98.15	-40.95	-5.85
Shares Outstanding (Basic)	6	0	2
Shares Outstanding (Diluted)	6	0	2
Shares Change	1413.96%	-81.03%	-
EPS (Basic)	-16.53	-104.40	-2.83
EPS (Diluted)	-16.53	-104.40	-2.83
Free Cash Flow	-89.44	-31.8	-5.38
Free Cash Flow Per Share	-15.06	-81.06	-2.60
EBITDA	-92.85	-34.57	-5.7
Depreciation & Amortization	3.69	1.44	0.15
EBIT	-96.54	-36.01	-5.85

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).